Surbhi Sidana

Also affiliated with Stanford Blood Center, Stanford Medicine, Stanford University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 23 papers. Top paper: “CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial”.

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Nature Medicine(2021)10.1038/s41591-021-01436-0

N/A

4.8DataRank · unranked

582 citations

Shabnum Patel, Lori Muffly, Nasheed Hossain, Jean Oak, John H. Baird +44 more

Longitudinal Patient Reported Outcomes with CAR-T Cell Therapy Versus Autologous and Allogeneic Stem Cell Transplant

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.05.004

N/A

2.0DataRank · unranked

66 citations

Amylou C. Dueck, Gita Thanarajasingam, Joan M. Griffin, Carrie A. Thompson, Urshila Durani +12 more

CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study

The Lancet(2024)10.1016/s0140-6736(24)00746-3

N/A

1.4DataRank · unranked

60 citations

John H. Baird, Anne Marijn Kramer, Hrishikesh K. Srinagesh, Shabnum Patel, Annie Kathleen Brown +43 more

Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD

Blood Advances(2023)10.1182/bloodadvances.2023011625

N/A

0.906DataRank · unranked

31 citations

Anna Pavlova, Robert Lowsky, Lori Muffly, Parveen Shiraz, Sally Arai +17 more

Donor regulatory T-cell therapy to prevent graft-versus-host disease

Blood(2025)10.1182/blood.2024026446

N/A

0.900DataRank · unranked

39 citations

Anna Pavlova, Alejandro Villar‐Prados, Cameron S. Bader, Bryan J. Xie, Lori Muffly +23 more

Antibody-Based Treatment Approaches in Multiple Myeloma

Current Hematologic Malignancy Reports(2021)10.1007/s11899-021-00624-6

N/A

0.727DataRank · unranked

12 citations

Surbhi Sidana, Hitomi Hosoya

Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy

Blood Advances(2021)10.1182/bloodadvances.2021004716

N/A

0.659DataRank · unranked

80 citations

Juliana Craig, John H. Baird, Jay Y. Spiegel, Lori Muffly, James L. Zehnder +16 more

Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.10.022

N/A

0.464DataRank · unranked

21 citations

Shaji Kumar, Raphael Fraser, Noel Estrada‐Merly, Sergio Giralt, Vaibhav Agrawal +22 more

Longitudinal graphics of patient-reported physical function in patients treated for hematologic malignancies

BMC Medical Research Methodology(2025)10.1186/s12874-025-02617-y

N/A

0.165DataRank · unranked

2 citations

Vishal Bhatnagar, Brie N. Noble, Tingyu Chen, Mallorie H. Fiero, Ron Hoffman +11 more

CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias

Research Square(2025)10.21203/rs.3.rs-7746241/v1

N/A

0.104DataRank · unranked

1 citations

Mark P. Hamilton, Nick Phillips, Troy Noordenbos, Jan Boegeholz, Takeshi Sugio +32 more

Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies

The Lancet Haematology(2022)10.1016/s2352-3026(22)00045-x

N/A

0DataRank · unranked

24 citations

Lori M Minasian, Vishal Bhatnagar, Franco Cavalli, R Angelo De Claro, Amylou C Dueck +35 more

Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern Era

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.05.010

N/A

0DataRank · unranked

13 citations

Juliana Craig, Stefan Torelli, Kristen Cunanan, María Iglesias, Sally Arai +14 more

Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.01.010

N/A

0DataRank · unranked

18 citations

Joseph Caveney, Bin Yao, Teresa Lopes Ramos, Jan Bögeholz, Kartoosh Heydari +17 more

Chimeric Antigen Receptor T Cell Therapy for Myeloma: Where Are We Now and What Is Needed to Move Chimeric Antigen Receptor T Cells Forward to Earlier Lines of Therapy? Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.10.022

N/A

0DataRank · unranked

42 citations

Binod Dhakal, Tania Jain, Olalekan O. Oluwole, Gunjan L. Shah, Surbhi Sidana +3 more

Phase 2 study of MGTA-145 + plerixafor for rapid and reliable hematopoietic stem cell (HSC) mobilization for autologous transplant in multiple myeloma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8023

N/A

0DataRank · unranked

1 citations

Andriyana K. Bankova, Hitomi Hosoya, Lori Muffly, Shaji Kumar, Laura Johnston +14 more

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

Blood(2024)10.1182/blood.2024025945

N/A

0DataRank · unranked

130 citations

Krina K. Patel, Lauren C. Peres, Radhika Bansal, Mehmet H. Kocoglu, Leyla Shune +33 more

IGVL gene region usage correlates with distinct clinical presentation in IgM vs non-IgM light chain amyloidosis

Blood Advances(2021)10.1182/bloodadvances.2020003671

N/A

0DataRank · unranked

8 citations

Surendra Dasari, Taxiarchis Kourelis, Angela Dispenzieri, David Murray, Rebecca L. King +5 more

CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity

Blood Advances(2024)10.1182/bloodadvances.2024012637

N/A

0DataRank · unranked

24 citations

Erin Craig, Cesar Gentille Sanchez, Alain Mina, John Tamaresis, Nadia Kirmani +27 more

Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-008975

N/A

0DataRank · unranked

16 citations

Eric Lau, Mark Hamilton, Anmol Goyal, Hrishi Srinagesh, Alexandria Jensen +26 more

Use of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.02.026

N/A

0DataRank · unranked

9 citations

Lori Muffly, Parveen Shiraz, Judith A. Shizuru, Laura Johnston, Sally Arai +9 more

Assessing Quality of Life and Symptoms in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.06.030

N/A

0DataRank · unranked

8 citations

Hermioni L. Amonoo, Anna Barata, Neel S. Bhatt, Manuel Espinoza‐Gutarra, Reena Jayani +15 more

Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafor in the Lenalidomide Era

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.04.016

N/A

0DataRank · unranked

23 citations

Abdullah Ladha, Lori Muffly, Parveen Shiraz, Gary Goldstein, Victoria Osgood +12 more

Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma

Blood Advances(2021)10.1182/bloodadvances.2020002732

N/A

0DataRank · unranked

194 citations

David J. Epstein, John Tamaresis, Zachary Ehlinger, Jay Y. Spiegel, Juliana Craig +18 more